News

Lupin’s GAVIS pipeline brings generic insomnia treatment to market

BY Michael Johnsen
BALTIMORE – Lupin Limited announced Tuesday that its U.S. subsidiary, Lupin Pharmaceuticals, has launched the first product from its GAVIS pipeline, Zolpidem Sublingual Tablets, 1.75 mg & 3.5 mg. The new entry is the generic equivalent of Purdue Pharma’s Intermezzo Sublingual Tablets, 1.75 mg & 3.5 mg. 
 
Lupin received final approval from the United States Food & Drug Administration earlier, as well as final clearance from the FTC with 180 days of exclusivity.
 
Zolpidem Sublingual Tablets is indicated for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep.
 
Intermezzo had U.S. sales of $9.5 million, according to IMS for the moving annual total ended December 2015.
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Pfizer walks away from Allergan deal following Treasury move on inversion

BY Michael Johnsen
NEW YORK – Pfizer on Wednesday announced that the merger agreement between Pfizer and Allergan has been terminated by mutual agreement of the companies. The decision was driven by the actions announced by the U.S. Department of Treasury on April 4, 2016, which the companies concluded qualified as an “Adverse Tax Law Change” under the merger agreement.
 
That Treasury announcement referenced by Pfizer and Allergan makes it more difficult for companies to invert. “Treasury has taken action twice to make it harder for companies to invert. These actions took away some of the economic benefits of inverting and helped slow the pace of these transactions, but we know companies will continue to seek new and creative ways to relocate their tax residence to avoid paying taxes here at home,” stated Treasury Secretary Jacob Lew on Monday. “Today, we are announcing additional actions to further rein in inversions and reduce the ability of companies to avoid taxes through earnings stripping.”
 
“Pfizer approached this transaction from a position of strength and viewed the potential combination as an accelerator of existing strategies,” stated Ian Read, chairman and CEO Pfizer. “We remain focused on continuing to enhance the value of our innovative and established businesses. Our most recent product launches, including Prevnar 13 in Adults, Ibrance, Eliquis and Xeljanz, have been well-received in the market, and we believe our late stage pipeline has several attractive commercial opportunities with high potential across several therapeutic areas,” he said. 
 
“We plan to make a decision about whether to pursue a potential separation of our innovative and established businesses by no later than the end of 2016, consistent with our original timeframe for the decision prior to the announcement of the potential Allergan transaction,” Read added. “As always, we remain committed to enhancing shareholder value.”
 
In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.
 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Beyond Her Blush delivers boxed beauty products curated by celebrity stylists

BY Gina Acosta

NEW YORK — A new company is looking to disrupt the beauty industry by offering consumers a box of products curated by celebrity stylists.

Beyond Her Blush says its boxes are full of products that aim to create the same looks seen on runways and in magazines. Each box comes with information on the stylists who curated the products, as well as a link for a video tutorial to demonstrate how each product is used together to achieve a specific look. The company says its goal is to give all women access to top quality products and instructions from highly regarded stylists.

Each box retails for about $20 a month with free shipping. 

"The service provided by Beyond Her Blush isn't just to provide women with trendy top quality products but rather includes an interactive experience with the customer," said Michelle Grundman, founder of Beyond Her Blush. "Since most women get their style inspiration from celebrities, I wanted to provide a service that would feature these looks from the individuals who know best- highly regarded celebrity stylists. By providing YouTube tutorials, the subscribers are able to use each product featured in the box to generate the exact same look stylists create for their celebrity clients."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?